Aurobindo Pharma Limited
2,295words
0turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
(E), MUMBAI -400 051 To The Corporate Relations Department BSE LIMITED Phiroz Jeejeebhoy Towers, 25th floor, Dalal Street, MUMBAI -400 001 Company Code No. AUROPHARMA Company Code No. 524804
₹ 8,286
ncial Highlights 4 Key Financial Highlights of the Quarter Revenue EBITDA Net Profit Q2FY26 ₹ 8,286 Cr ₹ 1,678 Cr ₹ 848 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Y-o-Y growth % 6.3% 7.1% 3.8%
₹ 1,678
ghts 4 Key Financial Highlights of the Quarter Revenue EBITDA Net Profit Q2FY26 ₹ 8,286 Cr ₹ 1,678 Cr ₹ 848 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Y-o-Y growth % 6.3% 7.1% 3.8% 5 5 Busi
₹ 848
Financial Highlights of the Quarter Revenue EBITDA Net Profit Q2FY26 ₹ 8,286 Cr ₹ 1,678 Cr ₹ 848 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Y-o-Y growth % 6.3% 7.1% 3.8% 5 5 Business Highl
₹ 7,796
hts of the Quarter Revenue EBITDA Net Profit Q2FY26 ₹ 8,286 Cr ₹ 1,678 Cr ₹ 848 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Y-o-Y growth % 6.3% 7.1% 3.8% 5 5 Business Highlights – Q2FY26 Reve
₹ 1,566
uarter Revenue EBITDA Net Profit Q2FY26 ₹ 8,286 Cr ₹ 1,678 Cr ₹ 848 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Y-o-Y growth % 6.3% 7.1% 3.8% 5 5 Business Highlights – Q2FY26 Revenue of ₹8,28
₹ 817
nue EBITDA Net Profit Q2FY26 ₹ 8,286 Cr ₹ 1,678 Cr ₹ 848 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Y-o-Y growth % 6.3% 7.1% 3.8% 5 5 Business Highlights – Q2FY26 Revenue of ₹8,286 crores w
6.3%
Q2FY26 ₹ 8,286 Cr ₹ 1,678 Cr ₹ 848 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Y-o-Y growth % 6.3% 7.1% 3.8% 5 5 Business Highlights – Q2FY26 Revenue of ₹8,286 crores with 6.3% growth YoY, dri
7.1%
₹ 8,286 Cr ₹ 1,678 Cr ₹ 848 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Y-o-Y growth % 6.3% 7.1% 3.8% 5 5 Business Highlights – Q2FY26 Revenue of ₹8,286 crores with 6.3% growth YoY, driven by
3.8%
286 Cr ₹ 1,678 Cr ₹ 848 Cr Q2FY25 ₹ 7,796 Cr ₹ 1,566 Cr ₹ 817 Cr Y-o-Y growth % 6.3% 7.1% 3.8% 5 5 Business Highlights – Q2FY26 Revenue of ₹8,286 crores with 6.3% growth YoY, driven by stron
₹8,286 crore
,566 Cr ₹ 817 Cr Y-o-Y growth % 6.3% 7.1% 3.8% 5 5 Business Highlights – Q2FY26 Revenue of ₹8,286 crores with 6.3% growth YoY, driven by strong US, Europe and Growth Markets performance Reported EBITDA
₹1,678 crore
th 6.3% growth YoY, driven by strong US, Europe and Growth Markets performance Reported EBITDA of ₹1,678 crores with a margin of 20.3%, driven by stable gross margins and operating efficiencies Net Capex of U
Advertisement